Ellen Chiniara

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Waltham, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Neil Lerner, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ellen Chiniara

Form 4 holding Chief Legal Officer

Kymera Therapeutics, Inc.

Security class
Common Stock
Shares / value
80,085
Estimated value
$2,483,003
Report date
03 Mar 2025
Price
$31.00
Ownership
Direct
Form 4 holding Chief Legal Officer

Kymera Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
55,000
Estimated value
Report date
03 Mar 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP & Chief Legal Officer

ALEXION PHARMACEUTICALS, INC.

Security class
Common Stock, par value $.0001 per share
Shares / value
0
Estimated value
Report date
21 Jul 2021
Price
$177.00
Ownership
Direct

Insider Reports Filed by Ellen Chiniara

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .